Highlights Topline data for ATH434-201 randomized, double-blind Phase 2 clinical trial on track for expected release by early February 2025ATH434-201 trial in early-stage MSA completed in November ...

Geographically, the consumer goods Goliath is trending back towards growth in Greater China. Organic sales in the region were ...

Procter & Gamble (NYSE: PG) proved again it is no gamble for investors, but a solid blue-chip company that can improve its ...

Republican Gov. Greg Gianforte’s administration is looking into moving a facility for people with developmental disabilities.